₩ 21350
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Solid dividends
Data is available to registered users only
Data is available to registered users only
About
Ilsung Is Co., Ltd. is a South Korean pharmaceutical company established in 1961. The company specializes in the research, development, and manufacturing of medicines, with a historical focus on antibiotics. It also has products in areas such as cardiovascular treatments, anesthetics, and contrast media through in-licensing partnerships with global pharmaceutical firms.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. In particular, the stock is overpriced on P/E, overvalued on P/FC.
Data is available to registered users only